Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429124 · ClinicalTrials.gov registry record · NA
Time Restricted Eating in Alzheimer's Disease
A NA study of Mild Cognitive Impairment (MCI), sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT06429124: Recruiting NA study of Mild Cognitive Impairment (MCI), sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
NCT06429124 is a NA study of Mild Cognitive Impairment (MCI) that is actively recruiting participants, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 30 participants, below the 158-participant average among 19 other Mild Cognitive Impairment (MCI) trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06429124, a NA study of Mild Cognitive Impairment (MCI), is actively recruiting participants, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot and feasibility study will enable the research team to determine the feasibility of implementing a time-restricted eating regimen among adults with mild cognitive impairment (MCI) and the impact of time-restricted eating on cognitive performance and biomarkers of metabolic health in this population. Study staff will execute the specific aims using a pre-post, non-randomized study design in which all participants receive the intervention. The intervention is a 16/8 time-restricted eating regimen characterized by fasting for 16 hours and eating within an 8-hour window on 5 days per week for 3 months. Assessments will be performed at baseline and after the 3-month time-restricted eating intervention with the following outcome measures. Outcome measures for feasibility include participant recruitment, retention and metrics of acceptability, safety, and adherence to the intervention. Outcome measures for cognitive performance and metabolic health include neuropsychological tests, blood biomarkers, and surveys of psychological well-being.
Primary Outcome
Insulin resistance will be estimated using HOMA-IR.
Conditions Studied
Interventions
- BEHAVIORAL Dietary Intervention
Study Locations (2)
Arizona
- Arizona State University, College of Health Solutions - Phoenix
- Barrow Neurological Institute, Division of Alzheimer's Disease - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2026-03-14 |
| Phase | NA |
What NCT06429124 shows while recruiting
NCT06429124 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 158-participant average among 19 other Mild Cognitive Impairment (MCI) trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Mild Cognitive Impairment (MCI) appearing as the primary indexed condition, and to 1 intervention - of which Dietary Intervention is the first listed.
NCT06429124 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06429124 about?
NCT06429124 is a clinical study titled "Time Restricted Eating in Alzheimer's Disease". This pilot and feasibility study will enable the research team to determine the feasibility of implementing a time-restricted eating regimen among adults with mild cognitive impairment (MCI) and the impact of time-restricted eating on cognitive performance and biomarkers of metabolic health in this ...
What is the current status of trial NCT06429124?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-03-15. Estimated completion is 2026-03-14.
What conditions does trial NCT06429124 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment (MCI).
What interventions are being tested in trial NCT06429124?
The interventions under investigation include: Dietary Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06429124?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429124 being conducted?
This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment (MCI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06429124's enrollment target sits among peer trials
30 12th of 19 higher than 7 of 19 other Mild Cognitive Impairment (MCI) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment (MCI) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Music for the Mind Study
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
RECRUITING · NA
-
Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
RECRUITING · NA
-
Working Memory Training in Patients with Mild Cognitive Impairment
RECRUITING · NA
-
Treating Insomnia in Mild Cognitive Impairment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI